The New Voice of Ukraine on MSN
European Commission bracing for Chinese trade disruption
"Europe — the European Commission, I want to emphasize — is preparing for the problem of a China shock, a new China shock, ...
The Commission is one of Brussels’ most coveted employers. Inside, officials describe mounting pressure, bureaucracy and ...
The European Commission approved the merger of Paramount Skydance and Warner Bros. Discovery on Wednesday, removing one of the few remaining obstacles to closing the $111 billion deal. As a condition ...
RBC Ukraine on MSN
European Commission reminds Poland of EU principles amid surge in aggression against Ukrainians
Brussels condemns hate crimes and hate speech Ukrainians in Poland are increasingly turning to the police over acts of aggression. The European Commission says it is monitoring compliance with EU ...
European Commission President Ursula von der Leyen was elected for a second term on Thursday after pledging to create a continental "defence union" and stay the course on Europe's green transition ...
IRIS2 is the European programme for secure satellite communications for commercial and military applications in areas of high ...
The European Commission gave a guarded welcome to new tariffs imposed by the United States on Friday, saying that the outcome was in line with a trade deal the two sides struck a year ago. The ...
The European Commission announced one of the world’s most ambitious goals to slash planet-heating pollution on Tuesday, but protesting farmers and upcoming elections could threaten its success, ...
The European Commission announced Friday that it sent a warning to TikTok for violations of its laws about safety standards for minors.
Tesla (TSLA) stock rises as EU FSD approval votes approach in October-November. Current 1.5M FSD subscriptions generate ...
The Chinese e-commerce platform failed to meet its obligations to stop the sale of illegal products. After sanctions against the social media platform X and the online marketplace Temu, this is the ...
AbbVie (NYSE: ABBV) today announced that the European Commission (EC) has approved RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of adult and adolescent patients 12 years and older with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results